Multiomics for Risk Stratification in Atherosclerotic Cardiovascular Disease
Circulation: Genomic and Precision Medicine · 2026-04 · 19 (2)
DOI: 10.1161/circgen.125.005451 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Circulation: Genomic and Precision Medicine, 2026-04. Verfasst von Liv Tybjærg Nordestgaard und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Biochemistry, Copenhagen University Hospital-Bispebjerg and Frederiksberg, Denmark (L.T.N.). Hauptthemen laut MEDLINE: Atherosclerosis. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 99 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Atherosclerotic cardiovascular disease (ASCVD) remains a leading cause of morbidity and mortality worldwide. Preventing ASCVD is of utmost importance; however, a large proportion of preventable cases is not discovered early enough to initiate relevant treatment. Risk stratification for ASCVD includes classical risk factors, such as sex, age, smoking habits, blood pressure, cholesterol levels, and diabetes. Current risk prediction models, including the Systematic Coronary Risk Evaluation 2 algorithms, are designed for individuals aged 40 to 69 years and relate to 10-year risk and not to lifetime risk, thereby being inaccurate for the young. Another problem is the underdiagnosis of events in women, thereby underestimating risk. Multiomics, encompassing genomics, epigenomics, transcriptomics, epitranscriptomics, proteomics, and metabolomics, offers new opportunities. Polygenic risk scores derived from genomic data may improve ASCVD risk classification. While genomic risk is established at inception, epigenomics captures the influence of environmental exposures over the lifespan through dynamic DNA modifications that regulate gene expression. Proteomics-based prediction reflects interactions between genetic inheritance, and modifiable and nonmodifiable influences. Transcriptomic analyses of carotid plaques have clustered human atherosclerotic lesions into distinct molecular subgroups, and changes in RNA methylation of circulating blood cells have been linked to clinical outcomes after ASCVD. Metabolomics identifies metabolic signatures, including lipid subclass alterations, amino acid imbalances, and inflammatory markers, all associated with cardiovascular disease incidence. In this review, we highlight current challenges, explore potential solutions, and discuss how integrating multiple omic layers through computational modeling (multiomics) could enhance patient stratification, optimize clinical management, and reduce the global burden of ASCVD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Clinical Biochemistry, Copenhagen University Hospital-Bispebjerg and Frederiksberg, Denmark (L.T.N.).
- Medical Research Council Integrative Epidemiology Unit, Population Health Sciences, University of Bristol, United Kingdom (L.T.N.).
- Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) MultiMedica, Milan, Italy (P.M., A.L.C.).
- Department of Pharmacological and Biomolecular Sciences, Università degli Studi di Milano, Italy (P.M., A.L.C.).
- Faculty of Pharmacy, Department of Medical Biochemistry, University of Belgrade, Serbia (M.S.).
- Division of Vascular Surgery, Department of Molecular Medicine and Surgery, and Center for Molecular Medicine, Karolinska Institutet and Karolinska University Hospital, Stockholm, Sweden (M.C., L. Matic).
ORCID-Profile: Liv Tybjærg Nordestgaard, Paolo Magni, Ljubica Matic, Nawar Dalila, Fábio Trindade, Brooke N Wolford, Núria Amigó, Alberico L Catapano, Lluìs Masana, Yvan Devaux
Zitieren
APA
Nordestgaard, L. T., Magni, P., Sopić, M., Chemaly, M., Matic, L., Dalila, N., Trindade, F., Wolford, B. N., Rodriguez-Hernandez, Z., Amigó, N., Catapano, A. L., Masana, L., & Devaux, Y. (2026). Multiomics for Risk Stratification in Atherosclerotic Cardiovascular Disease. Circulation: Genomic and Precision Medicine, 19(2). https://doi.org/10.1161/circgen.125.005451
Vancouver
Nordestgaard LT, Magni P, Sopić M, Chemaly M, Matic L, Dalila N, et al. Multiomics for Risk Stratification in Atherosclerotic Cardiovascular Disease. Circulation: Genomic and Precision Medicine. 2026;19(2). doi:10.1161/circgen.125.005451
BibTeX
@article{Nordestgaard2026,
author = {Nordestgaard, Liv Tybjærg and Magni, Paolo and Sopić, Miron and Chemaly, Melody and Matic, Ljubica and Dalila, Nawar and Trindade, Fábio and Wolford, Brooke N and Rodriguez-Hernandez, Zulema and Amigó, Núria and Catapano, Alberico L and Masana, Lluìs and Devaux, Yvan},
title = {Multiomics for Risk Stratification in Atherosclerotic Cardiovascular Disease},
journal = {Circulation: Genomic and Precision Medicine},
year = {2026},
volume = {19},
number = {2},
doi = {10.1161/circgen.125.005451}
}
EUVIMED